MYDICAR Trademark

Trademark Overview

On Thursday, October 6, 2005, a trademark application was filed for MYDICAR with the United States Patent and Trademark Office. The USPTO has given the MYDICAR trademark a serial number of 78979488. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 17, 2018. This trademark is owned by Celladon Corporation. The MYDICAR trademark is filed in the Pharmaceutical Products category with the following description:

Biological product, namely, a gene transfer product composed of a recombinant adeno-associated viral vector for medical use
mydicar

General Information

Serial Number78979488
Word MarkMYDICAR
Filing DateThursday, October 6, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 17, 2018
Registration Number3370955
Registration DateTuesday, January 15, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2006

Trademark Statements

Goods and ServicesBiological product, namely, a gene transfer product composed of a recombinant adeno-associated viral vector for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 17, 2018
Primary Code005
First Use Anywhere DateWednesday, May 9, 2007
First Use In Commerce DateWednesday, May 9, 2007

Trademark Owner History

Party NameCelladon Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameCelladon Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameCelladon Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Friday, August 17, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, January 15, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, January 20, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, January 20, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, January 10, 2014REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, January 20, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 10, 2014TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 15, 2008REGISTERED-PRINCIPAL REGISTER
Thursday, December 13, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, December 13, 2007ASSIGNED TO LIE
Wednesday, November 7, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 7, 2007STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 11, 2007USE AMENDMENT FILED
Wednesday, November 7, 2007DIVISIONAL PROCESSING COMPLETE
Monday, October 15, 2007DIVISIONAL REQUEST RECEIVED
Monday, October 15, 2007PAPER RECEIVED
Thursday, October 11, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, July 31, 2007EXTENSION 1 GRANTED
Tuesday, April 17, 2007EXTENSION 1 FILED
Tuesday, April 17, 2007TEAS EXTENSION RECEIVED
Tuesday, October 24, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 1, 2006PUBLISHED FOR OPPOSITION
Wednesday, July 12, 2006NOTICE OF PUBLICATION
Thursday, June 15, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 9, 2006ASSIGNED TO LIE
Monday, June 5, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 30, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 3, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 3, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 14, 2006NON-FINAL ACTION E-MAILED
Friday, April 14, 2006NON-FINAL ACTION WRITTEN
Monday, April 10, 2006ASSIGNED TO EXAMINER
Tuesday, October 11, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

mydicar product associated viral medical adeno vector composed namely gene transfer